Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.
Cotte L, Ferry T, Pugliese P, Valantin MA, Allavena C, Cabié A, Poizot-Martin I, Rey D, Duvivier C, Cheret A, Dellamonica P, Pradat P, Parienti JJ; Dat’AIDS study group. Cotte L, et al. Among authors: ferry t. PLoS One. 2017 Feb 2;12(2):e0170661. doi: 10.1371/journal.pone.0170661. eCollection 2017. PLoS One. 2017. PMID: 28152047 Free PMC article.
Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.
Saison J, Ferry T, Demaret J, Maucort Boulch D, Venet F, Perpoint T, Ader F, Icard V, Chidiac C, Monneret G; Lyon HIV Cohort Study. Saison J, et al. Among authors: ferry t. Clin Exp Immunol. 2014 Jun;176(3):401-9. doi: 10.1111/cei.12278. Clin Exp Immunol. 2014. PMID: 24460818 Free PMC article.
Increased Regulatory T-Cell Percentage Contributes to Poor CD4(+) Lymphocytes Recovery: A 2-Year Prospective Study After Introduction of Antiretroviral Therapy.
Saison J, Maucort Boulch D, Chidiac C, Demaret J, Malcus C, Cotte L, Poitevin-Later F, Miailhes P, Venet F, Trabaud MA, Monneret G, Ferry T. Saison J, et al. Among authors: ferry t. Open Forum Infect Dis. 2015 May 1;2(2):ofv063. doi: 10.1093/ofid/ofv063. eCollection 2015 Apr. Open Forum Infect Dis. 2015. PMID: 26110165 Free PMC article.
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.
Poizot-Martin I, Naqvi A, Obry-Roguet V, Valantin MA, Cuzin L, Billaud E, Cheret A, Rey D, Jacomet C, Duvivier C, Pugliese P, Pradat P, Cotte L; Hepadat'AIDS Study Group. Poizot-Martin I, et al. PLoS One. 2015 Oct 21;10(10):e0141164. doi: 10.1371/journal.pone.0141164. eCollection 2015. PLoS One. 2015. PMID: 26488159 Free PMC article.
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.
Raffi F, Le Moing V, Assuied A, Habak S, Spire B, Cazanave C, Billaud E, Dellamonica P, Ferry T, Fagard C, Leport C; ANRS CO8 COPILOTE Study Group. Raffi F, et al. Among authors: ferry t. J Antimicrob Chemother. 2017 Jan;72(1):240-245. doi: 10.1093/jac/dkw369. Epub 2016 Sep 13. J Antimicrob Chemother. 2017. PMID: 27629069
426 results